BC

Broadfin Capital Portfolio holdings

AUM $403M
1-Year Est. Return 74.97%
This Quarter Est. Return
1 Year Est. Return
+74.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$645M
AUM Growth
-$45.1M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
57
New
Increased
Reduced
Closed

Top Buys

1
+$15.1M
2
+$6.16M
3
+$5.74M
4
RGLS
Regulus Therapeutics
RGLS
+$5.37M
5
BAX icon
Baxter International
BAX
+$4.1M

Top Sells

1
+$28.5M
2
+$17.9M
3
+$15.5M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$12.6M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$12.2M

Sector Composition

1 Healthcare 91.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$5.74M 0.85%
+50,470
27
$5.71M 0.85%
81,622
-45,060
28
$5.42M 0.8%
17,885
-10,474
29
$5.37M 0.79%
+35,788
30
$4.94M 0.73%
140,954
-121,546
31
$4.88M 0.72%
88,000
+32,100
32
$4.1M 0.61%
+65,300
33
$3.96M 0.59%
+78,500
34
$3.9M 0.58%
+133,700
35
$3.15M 0.47%
64,800
-245,200
36
$3.01M 0.45%
3,389
+1,732
37
$2.67M 0.4%
71,429
+46,477
38
$2.57M 0.38%
1,004,352
-90,192
39
$2.13M 0.31%
+141,000
40
$781K 0.12%
188
+94
41
$85K 0.01%
4,783
-1,878
42
– –
-66,700
43
– –
-52,700
44
– –
0
45
– –
-681,346
46
– –
-594,533
47
– –
0
48
– –
-2,218
49
– –
-1,000,000
50
– –
-77,934
1
2
3